Spyre Therapeutics (SYRE) Earnings Date & Reports

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

SYRE is expected to report earnings to rise 39.63% to -83 cents per share on July 31

Spyre Therapeutics SYRE Stock Earnings Reports

Q2'25

Est.

$-0.84

Q1'25

Beat

by $0.24

Q4'24

Beat

by $0.22

Q3'24

Missed

by $0.54

Q2'24

Beat

by $0.09

The last earnings report on May 08 showed earnings per share of -60 cents, beating the estimate of -83 cents. With 716.70K shares outstanding, the current market capitalization sits at 849.89M.

View a ticker or compare two or three

Compare

SYRE